Practical Considerations in Convalescent Plasma Therapy for Coronavirus Disease 2019 / 대한수혈학회지
Korean Journal of Blood Transfusion
;
: 67-69, 2020.
Artículo
| WPRIM
| ID: wpr-836480
ABSTRACT
Convalescent plasma therapy has been used to achieve passive immunization against diverse infectious agents by administering pathogen-specific antibodies. Coronavirus disease 19 (COVID-19), which originated in Wuhan, China, has recently become a major concern all over the world. There are no specific treatment recommendations for COVID-19 because of the lack of knowledge and evidence about this virus. Convalescent plasma therapy can be used as an empirical and investigational treatment for COVID-19, and so we briefly describe the main issues related to convalescent plasma therapy from the perspective of transfusion medicine.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Guía de Práctica Clínica
Revista:
Korean Journal of Blood Transfusion
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS